Increased matrix metalloproteinase 9 activity in mild cognitive impairment.

Journal of Neuropathology and Experimental Neurology
Martin A BrunoA Claudio Cuello

Abstract

Nerve growth factor (NGF)-dependent cholinergic basal forebrain neurons degenerate during the progression of Alzheimer disease (AD). Elevated proNGF and reduced levels of the TrkA high-affinity NGF receptor occur in prodromal and advanced stages of AD. We recently described a protease cascade responsible for the conversion of proNGF to mature NGF (mNGF) in which matrix metalloproteinase 9 (MMP-9) degrades mNGF in the extracellular space. To determine whether this proteolytic cascade is altered during the progression of AD, we examined human frontal and parietal cortex tissues from aged subjects with a clinical diagnosis of AD, mild cognitive impairment, or no cognitive impairment. The analysis demonstrated greater MMP-9 activity in both AD and mild cognitive impairment compared with no cognitive impairment brain samples (p < 0.01), which supports the notion that a metabolic failure in the NGF-maturation/degradation pathway may be associated with an exacerbated degradation of mNGF in the cerebral cortex in early AD. Moreover, there were inverse correlations between Global Cognitive Score and Mini-Mental State Examination score and MMP-9 activity. These findings suggest that a reduction in mNGF as a consequence of MMP-9-mediated ...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Apr 1, 1991·The International Journal of Neuroscience·M AlbertH H Funkenstein
Jun 1, 1989·Archives of Neurology·L B GoldsteinJ N Davis
Jan 1, 1986·Annals of the New York Academy of Sciences·H M Wisniewski, A Rabe
Oct 27, 1995·Science·H Thoenen
Dec 30, 1994·Biochemical and Biophysical Research Communications·A E RoherR Fridman
Nov 1, 1996·The American Journal of Physiology·J S Beckman, W H Koppenol
Jan 1, 1996·Progress in Brain Research·A C Cuello
Jul 1, 1997·Neurobiology of Aging·J W GeddesW R Markesbery
Apr 28, 1999·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·D A BennettR S Wilson
Jul 23, 1999·Experimental Neurology·E J MufsonJ H Kordower
Dec 1, 2001·Science·R LeeB L Hempstead
Jan 17, 2002·The Journal of Comparative Neurology·Elliott J MufsonJeffrey H Kordower
Jul 24, 2002·Neurology·D A BennettJ Bach
Jan 24, 2003·Critical Reviews in Biochemistry and Molecular Biology·Philippe E Van den SteenGhislain Opdenakker
Apr 12, 2003·Neurochemistry International·Stefan LorenzlM Flint Beal
Jun 6, 2003·Brain Research·Hans-Joachim LüthReinhard Schliebs
Jun 11, 2003·Neurology·L L BarnesD A Bennett
Feb 27, 2004·Nature·David R Kaplan, Freda D Miller
Feb 27, 2004·Nature·Anders NykjaerClaus M Petersen
Jun 3, 2004·Annals of Neurology·Marsel MesulamSandra Weintraub
Jun 26, 2004·Journal of Neuropathology and Experimental Neurology·Shiyong PengMargaret Fahnestock
Aug 25, 2004·Journal of Internal Medicine·R C Petersen

❮ Previous
Next ❯

Citations

Nov 22, 2011·Acta Neuropathologica·Elliott J MufsonStephen W Scheff
Apr 27, 2012·Inflammopharmacology·G Joseph BroussardGloria J Klapstein
Nov 19, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Santiago RiveraDiane M Jaworski
Feb 13, 2014·Brain : a Journal of Neurology·M Florencia IulitaA Claudio Cuello
Jun 26, 2014·Trends in Pharmacological Sciences·M Florencia Iulita, A Claudio Cuello
Jul 31, 2013·Molecular Pain·Maria OsikowiczAlfredo Ribeiro-da-Silva
Jun 21, 2011·Neuroscience Letters·Nootchanat MairuaePoonlarp Cheepsunthorn
Nov 26, 2015·Journal of Alzheimer's Disease : JAD·Erica M Weekman, Donna M Wilcock
Jan 21, 2010·Neuroscience Letters·Elliott J MufsonAnders Nykjaer
Oct 18, 2011·Journal of Neuropathology and Experimental Neurology·James Scott MinersSeth Love
Oct 26, 2012·Journal of Neuropathology and Experimental Neurology·Elliott J MufsonStephen W Scheff
Aug 13, 2011·Developmental Neurobiology·Lorraine E Dansie, Iryna M Ethell
Nov 6, 2015·Mediators of Inflammation·Marjana BrkicRoosmarijn E Vandenbroucke
May 1, 2012·Biomolecules & Therapeutics·Sang-Sun Yoon, Sangmee Ahn Jo
Mar 19, 2011·Neurobiology of Aging·Maria Teresa FerrettiA Claudio Cuello
Sep 25, 2015·Journal of Alzheimer's Disease : JAD·Beatrice Terni, Isidro Ferrer
Jul 23, 2014·BioMed Research International·Xiang-Xiang WangLan Tan
May 14, 2011·Free Radical Biology & Medicine·Rodney P Guttmann, Sarbani Ghoshal
Sep 10, 2013·Neuroscience·S SolemanJ W Fawcett
Oct 14, 2014·Frontiers in Aging Neuroscience·J Scott MinersSeth Love
Apr 29, 2016·Annals of Neurology·Alexander EgebergJacob P Thyssen
Jul 28, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·M Florencia IulitaA Claudio Cuello
May 22, 2013·American Journal of Alzheimer's Disease and Other Dementias·Khanh vinh quoc Lương, Lan Thi Hoàng Nguyen
Jan 17, 2013·American Journal of Alzheimer's Disease and Other Dementias·Khanh Vinh Quoc Lu'o'ng, Lan Thi Hoàng Nguyen
Jun 22, 2016·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Ralf G RempeBjörn Bauer
Jul 28, 2016·International Journal of Molecular Sciences·Akinori Tokito, Michihisa Jougasaki
Jan 19, 2018·International Journal of Molecular Sciences·Marzena Wyganowska-ŚwiątkowskaJerzy Jankun
Jan 8, 2018·Journal of the American Heart Association·Chongke ZhongJiang He
Jun 6, 2018·Journal of Alzheimer's Disease : JAD·Archontia KaminariAthina Tzinia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Basal Forebrain & Food Avoidance

Neurons in the basal forebrain play specific roles in regulating feeding. Here are the latest discoveries pertaining to the basal forebrain and food avoidance.